Qube Research & Technologies (QRT)
BLTE

Qube Research & Technologies (QRT)’s Belite Bio BLTE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
+12,171
New +$1.87M ﹤0.01% 2155
2023
Q4 		– Sell
-525
Closed -$16.6K – 4352
2023
Q3 		$16.6K Buy
+525
New +$13.2K ﹤0.01% 3201
2023
Q2 		– Sell
-7,528
Closed -$219K – 2416
2023
Q1 		$219K Sell
7,528
-3,093
-29% -$94K ﹤0.01% 1898
2022
Q4 		$325K Buy
10,621
+179
+2% +$5.27K ﹤0.01% 1629
2022
Q3 		$353K Buy
10,442
+3,802
+57% +$131K ﹤0.01% 1579
2022
Q2 		$207K Buy
+6,640
New +$124K ﹤0.01% 1726

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLTE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Belite Bio (BLTE) in Q2 2026: 12,171 shares worth $1.87M. The stake represents ﹤0.01% of the portfolio and ranks #2155 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BLTE as recently as Q3 2023.

Qube Research & Technologies (QRT) first reported a position in BLTE in Q2 2022 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 12,171 shares of Belite Bio worth $1.87M as of Q2 2026.
  • Belite Bio was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Belite Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2155 holding.
  • Qube Research & Technologies (QRT) first reported a position in Belite Bio in Q2 2022 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.